Eszter Herczenik
Overview
Explore the profile of Eszter Herczenik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wasiluk T, So-Osman C, van den Burg P, Herczenik E, Al-Riyami A
Transfus Apher Sci
. 2022 Dec;
62(1):103633.
PMID: 36572573
No abstract available.
2.
Al-Riyami A, Burnouf T, Wood E, Devine D, Oreh A, Apelseth T, et al.
Vox Sang
. 2022 Mar;
117(6):822-830.
PMID: 35262978
Background And Objectives: The coronavirus disease 2019 (COVID-19) pandemic has impacted blood systems worldwide. Challenges included maintaining blood supplies and initiating the collection and use of COVID-19 convalescent plasma (CCP)....
3.
Al-Riyami A, Masser B, Herczenik E, Arora S, Boateng L, Dinardo C, et al.
Vox Sang
. 2022 Jan;
117(5):685-692.
PMID: 35023178
Background And Objectives: The COVID-19 pandemic brought about changes to daily life as measures to contain the spread of the virus increased across the world. The aim of this survey...
4.
De Angelis V, Koekman A, Weeterings C, Roest M, de Groot P, Herczenik E, et al.
PLoS One
. 2014 Sep;
9(9):e108282.
PMID: 25264625
Background: The endocannabinoid system has previously been implicated in the regulation of neurons and inflammatory cells. Additionally, it has been reported that endocannabinoid receptors are present on circulating platelets, but...
5.
Flinsenberg T, Janssen W, Herczenik E, Boross P, Nederend M, Jongeneel L, et al.
Clin Immunol
. 2014 Sep;
155(1):108-117.
PMID: 25242138
We identified a novel Q27W FcγRIIa variant that was found more frequently in common variable immunodeficiency (CVID) or CVID-like children. We analyzed the possible functional consequence of the Q27W FcγRIIa...
6.
van Haren S, Wroblewska A, Herczenik E, Kaijen P, Ruminska A, Ten Brinke A, et al.
PLoS One
. 2013 Nov;
8(11):e80239.
PMID: 24244658
The formation of inhibitory antibodies directed against coagulation factor VIII (FVIII) is a severe complication in the treatment of hemophilia A patients. The induction of anti-FVIII antibodies is a CD4(+)...
7.
Wroblewska A, van Haren S, Herczenik E, Kaijen P, Ruminska A, Jin S, et al.
Blood
. 2012 Apr;
119(22):5294-300.
PMID: 22498747
Development of neutralizing Abs to blood coagulation factor VIII (FVIII) provides a major complication in hemophilia care. In this study we explored whether modulation of the uptake of FVIII by...
8.
Sorvillo N, Pos W, van den Berg L, Fijnheer R, Martinez-Pomares L, Geijtenbeek T, et al.
Blood
. 2012 Feb;
119(16):3828-35.
PMID: 22289891
ADAMTS13 is a plasma metalloproteinase that regulates platelet adhesion and aggregation by cleaving ultra-large VWF multimers on the surfaces of endothelial cells. Autoantibodies directed against ADAMTS13 prohibit the processing of...
9.
van Haren S, Wroblewska A, Fischer K, Voorberg J, Herczenik E
Blood Rev
. 2011 Nov;
26(1):43-9.
PMID: 22036515
Generation of inhibitory antibodies upon repeated FVIII infusion represents a major complication in hemophilia care. Professional antigen presenting cells (APCs) are crucial for orchestration of humoral immune responses. APCs are...
10.
Herczenik E, van Haren S, Wroblewska A, Kaijen P, van den Biggelaar M, Meijer A, et al.
J Allergy Clin Immunol
. 2011 Oct;
129(2):501-9, 509.e1-5.
PMID: 21962992
Background: The uptake and processing of blood coagulation factor VIII (FVIII) by antigen-presenting cells and the subsequent presentation of FVIII-derived peptides to CD4(+) T cells direct the immune response to...